Molecular Imaging

Nuclear medicine groups launch effort to standardize PET imaging

By AuntMinnie.com staff writers

PET system accreditation methods vary widely across clinical research organizations, sponsors, and professional networks.

December 17, 2025

RadioMedix secures Th-228 supply

By AuntMinnie.com staff writers

The supply will support the company's advancing cancer therapeutics pipeline.

December 17, 2025

Early PET/CT feasible in women with suspected breast cancer

Early imaging is not only more patient-friendly but also has the potential to simplify clinical workflows.

December 12, 2025

2025 12 12 Fapi Breast Cancer Thumbnail

Phase I trial reveals the potential of a new PSMA-PET tracer

The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.

December 9, 2025

Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).

TVR-PET/CT shows promise in primary hyperparathyroidism

Gallium-68 trivehexin PET/CT was superior for identifying lesions over technetium-99m sestamibi SPECT.

December 8, 2025

PiB-PET/CT detects subtypes in cardiac amyloidosis

PiB-PET/CT shows strong promise as a next-generation diagnostic tool for cardiac amyloidosis.

December 5, 2025

SNMMI notes pros and cons in CMS final 2026 OPPS rule

By AuntMinnie.com staff writers

The final rule includes two new Healthcare Common Procedure Coding System (HCPCS) codes relevant to nuclear medicine.

November 26, 2025

New SPECT/CT tracer visualizes distribution of ALS drug

Tofersen has been approved for treating amyotrophic lateral sclerosis (ALS), but its regional brain uptake is not fully understood.

November 25, 2025

SPECT imaging of Tc-99m MAG3-tofersen in healthy human volunteers. (A) Maximum-intensity-projection images showing distribution of Tc-99m MAG3-tofersen in humans (n = 3) one, four, and 24 hours after intrathecal injection. Time–activity curves derived from SPECT data measuring activity in ROIs in CNS (lumbar, thoracic, and cervical spine ROIs include both cord and proximal CSF) (B), kidneys and liver (C), and brain atlas (D).

ConcertAI launches new reimbursement tool

By AuntMinnie.com staff writers

AI-powered platform tailored to payer requirements for reimbursable imaging biomarkers.

November 21, 2025

Money Bills Sky Line

UCLA to launch department of nuclear medicine and theranostics

By AuntMinnie.com staff writers

The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.

November 19, 2025

Nuclearmedicine

Cardiology network extends adoption of GEHC's Flyrcado

By AuntMinnie.com staff writers

After a successful pilot, Cardiovascular Associates of America plans to expand adoption of GEHC's radiotracer Flyrcado.

November 19, 2025

Pet Scanner Bore 400

Stress coping may protect against cognitive decline

Adaptive coping was associated with better cognitive trajectories, independent of amyloid and tau PET brain pathology.

November 18, 2025

Page 1 of 617